{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:46:24Z","timestamp":1791103584531,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T00:00:00Z","timestamp":1127952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T00:00:00Z","timestamp":1127952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.gt.3302650","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T12:38:59Z","timestamp":1127997539000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer"],"prefix":"10.1038","volume":"13","author":[{"given":"A","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Allamarvdasht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-J","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-S","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B C","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Y","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,29]]},"reference":[{"key":"BF3302650_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1566524024605798","volume":"2","author":"JY Chou","year":"2002","unstructured":"Chou JY, Matern D, Mansfield BC, Chen YT . Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002; 2: 121\u2013143.","journal-title":"Curr Mol Med"},{"key":"BF3302650_CR2","first-page":"1521","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Y-T Chen","year":"2001","unstructured":"Chen Y-T . Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill Inc.: New York, 2001, pp 1521\u20131551."},{"key":"BF3302650_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM197602192940805","volume":"294","author":"HL Greene","year":"1976","unstructured":"Greene HL, Slonim AE, O'Neill Jr JA, Burr IM . Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. N Engl J Med 1976; 294: 423\u2013425.","journal-title":"N Engl J Med"},{"key":"BF3302650_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJM198401193100306","volume":"310","author":"YT Chen","year":"1984","unstructured":"Chen YT, Cornblath M, Sidbury JB . Cornstarch therapy in type I glycogen storage disease. N Engl J Med 1984; 310: 171\u2013175.","journal-title":"N Engl J Med"},{"key":"BF3302650_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.8211187","volume":"262","author":"K-J Lei","year":"1993","unstructured":"Lei K-J et al. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 1993; 262: 580\u2013583.","journal-title":"Science"},{"key":"BF3302650_CR6","doi-asserted-by":"crossref","first-page":"21482","DOI":"10.1016\/S0021-9258(20)80563-8","volume":"268","author":"LL Shelly","year":"1993","unstructured":"Shelly LL et al. Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Biol Chem 1993; 268: 21482\u201321485.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/abbi.1998.0849","volume":"358","author":"C-J Pan","year":"1998","unstructured":"Pan C-J et al. Ontogeny of the murine glucose-6-phosphatase system. Arch Biochem Biophys 1998; 358: 17\u201324.","journal-title":"Arch Biochem Biophys"},{"key":"BF3302650_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-4613-2355-6_11","volume-title":"The Enzymes of Biological Membrane","author":"RC Nordlie","year":"1985","unstructured":"Nordlie RC, Sukalski KA . Multifunctional glucose-6-phosphatase: a critical review. In: Martonosi AN (ed). The Enzymes of Biological Membrane, 2nd edn. Plenum Press: New York, 1985, pp 349\u2013398."},{"key":"BF3302650_CR9","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1074\/jbc.273.11.6144","volume":"273","author":"C-J Pan","year":"1998","unstructured":"Pan C-J et al. Transmembrane topology of glucose-6-phosphatase. J Biol Chem 1998; 273: 6144\u20136148.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR10","doi-asserted-by":"publisher","first-page":"32837","DOI":"10.1074\/jbc.M201853200","volume":"277","author":"A Ghosh","year":"2002","unstructured":"Ghosh A et al. The catalytic center of glucose-6-phosphatase: His176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis. J Biol Chem 2002; 277: 32837\u201332842.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4419-9023-5_13","volume-title":"Membrane Transporter Diseases","author":"JY Chou","year":"2003","unstructured":"Chou JY, Mansfield BC . Glucose-6-phosphate transporter: the key to glycogen storage disease type Ib. In: Broer S, Wagner CA (eds). Membrane Transporter Diseases. Kluwer Academic\/Plenum Publisher: New York, 2003, pp 191\u2013205."},{"key":"BF3302650_CR12","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1074\/jbc.274.9.5532","volume":"274","author":"H Hiraiwa","year":"1999","unstructured":"Hiraiwa H et al. Inactivation of the glucose-6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem 1999; 274: 5532\u20135536.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng0696-203","volume":"13","author":"K-J Lei","year":"1996","unstructured":"Lei K-J et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse. Nat Genet 1996; 13: 203\u2013209.","journal-title":"Nat Genet"},{"key":"BF3302650_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1074\/jbc.275.2.828","volume":"275","author":"A Zingone","year":"2000","unstructured":"Zingone A et al. Correction of glycogen storage disease type 1a in a mouse model by gene therapy. J Biol Chem 2000; 275: 828\u2013832.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR15","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/hmg\/11.18.2155","volume":"11","author":"M-S Sun","year":"2002","unstructured":"Sun M-S et al. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet 2002; 11: 2155\u20132164.","journal-title":"Hum Mol Genet"},{"key":"BF3302650_CR16","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","volume":"78","author":"CE Thomas","year":"2004","unstructured":"Thomas CE, Storm TA, Huang Z, Kay MA . Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 3110\u20133122.","journal-title":"J Virol"},{"key":"BF3302650_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","volume":"38","author":"DM McCarty","year":"2004","unstructured":"McCarty DM, Young Jr SM, Samulski RJ . Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004; 38: 819\u2013845.","journal-title":"Annu Rev Genet"},{"key":"BF3302650_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.gt.3302233","volume":"11","author":"TR Flotte","year":"2004","unstructured":"Flotte TR . Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2004; 11: 805\u2013810.","journal-title":"Gene Therapy"},{"key":"BF3302650_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/1566523034578131","volume":"3","author":"L Tenenbaum","year":"2003","unstructured":"Tenenbaum L, Lehtonen E, Monahan PE . Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr Gene Ther 2003; 3: 545\u2013565.","journal-title":"Curr Gene Ther"},{"key":"BF3302650_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","volume":"10","author":"K Benihoud","year":"1999","unstructured":"Benihoud K, Yeh P, Perricaudet M . Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440\u2013447.","journal-title":"Curr Opin Biotechnol"},{"key":"BF3302650_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0169-409X(00)00125-3","volume":"46","author":"JM Wilson","year":"2001","unstructured":"Wilson JM . Adenovirus-mediated gene transfer to liver. Adv Drug Deliv Rev 2001; 46: 205\u2013209.","journal-title":"Adv Drug Deliv Rev"},{"key":"BF3302650_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1006\/mthe.2000.0219","volume":"2","author":"H Chao","year":"2000","unstructured":"Chao H et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619\u2013623.","journal-title":"Mol Ther"},{"key":"BF3302650_CR23","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302650_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1566523034578285","volume":"3","author":"D Grimm","year":"2003","unstructured":"Grimm D, Kay MA . From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 2003; 3: 281\u2013304.","journal-title":"Curr Gene Ther"},{"key":"BF3302650_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","volume":"76","author":"JE Rabinowitz","year":"2002","unstructured":"Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791\u2013801.","journal-title":"J Virol"},{"key":"BF3302650_CR26","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/sj.gt.3302046","volume":"10","author":"SA Loiler","year":"2003","unstructured":"Loiler SA et al. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Therapy 2003; 10: 1551\u20131558.","journal-title":"Gene Therapy"},{"key":"BF3302650_CR27","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0735-1097(01)01627-8","volume":"38","author":"LM Ruilope","year":"2001","unstructured":"Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF . Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001; 38: 1782\u20131787.","journal-title":"J Am Coll Cardiol"},{"key":"BF3302650_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1525-0016(03)00012-1","volume":"7","author":"B Hauck","year":"2003","unstructured":"Hauck B, Chen L, Xiao W . Generation and characterization of chimeric recombinant AAV vectors. Mol Ther 2003; 7: 419\u2013425.","journal-title":"Mol Ther"},{"key":"BF3302650_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0378-1119(96)00576-8","volume":"190","author":"S Ponnazhagan","year":"1997","unstructured":"Ponnazhagan S et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 1997; 190: 203\u2013210.","journal-title":"Gene"},{"key":"BF3302650_CR30","first-page":"195","volume":"246","author":"TM Daly","year":"2004","unstructured":"Daly TM . AAV-mediated gene transfer to the liver. Methods Mol Biol 2004; 246: 195\u2013199.","journal-title":"Methods Mol Biol"},{"key":"BF3302650_CR31","doi-asserted-by":"publisher","first-page":"47098","DOI":"10.1074\/jbc.M309472200","volume":"278","author":"J-J Shieh","year":"2003","unstructured":"Shieh J-J, Pan C-J, Mansfield BC, Chou JY . Glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem 2003; 278: 47098\u201347103.","journal-title":"J Biol Chem"},{"key":"BF3302650_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0014-5793(03)00903-7","volume":"551","author":"O Guionie","year":"2003","unstructured":"Guionie O, Clottes E, Stafford K, Burchell A . Identification and characterisation of a new human glucose-6-phosphatase isoform. FEBS Lett 2003; 551: 159\u2013164.","journal-title":"FEBS Lett"},{"key":"BF3302650_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2337\/diabetes.49.6.969","volume":"49","author":"JN Clore","year":"2000","unstructured":"Clore JN, Stillman J, Sugerman H . Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 2000; 49: 969\u2013974.","journal-title":"Diabetes"},{"key":"BF3302650_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1006\/bbrc.1994.2719","volume":"205","author":"Z Liu","year":"1994","unstructured":"Liu Z et al. Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Commun 1994; 205: 680\u2013686.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302650_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1172\/JCI117733","volume":"95","author":"BA Haber","year":"1995","unstructured":"Haber BA et al. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 1995; 95: 832\u2013841.","journal-title":"J Clin Invest"},{"key":"BF3302650_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/104303401300042500","volume":"12","author":"L Xu","year":"2001","unstructured":"Xu L et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 2001; 12: 563\u2013573.","journal-title":"Hum Gene Ther"},{"key":"BF3302650_CR37","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","volume":"10","author":"D Grimm","year":"1998","unstructured":"Grimm D, Kern A, Rittner K, Kleinschmidt JA . Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 10: 2745\u20132760.","journal-title":"Hum Gene Ther"},{"key":"BF3302650_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","volume":"28","author":"S Zolotukhin","year":"2002","unstructured":"Zolotukhin S et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2002; 28: 158\u2013167.","journal-title":"Methods"},{"key":"BF3302650_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.gt.3301068","volume":"7","author":"AC Nathwani","year":"2000","unstructured":"Nathwani AC et al. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38\u2212 subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Therapy 2000; 7: 183\u2013195.","journal-title":"Gene Therapy"},{"key":"BF3302650_CR40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0076-6879(00)16760-6","volume":"316","author":"WW Hauswirth","year":"2000","unstructured":"Hauswirth WW, Lewin AS, Zolotukhin S, Muzyczka N . Production and purification of recombinant adeno-associated virus. Methods Enzymol 2000; 316: 743\u2013761.","journal-title":"Methods Enzymol"},{"key":"BF3302650_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6336(81)80001-0","volume":"14","author":"HF Teutsch","year":"1981","unstructured":"Teutsch HF . Chemomorphology of liver parenchyma. Qualitative histochemical distribution patterns and quantitative sinusoidal profiles of G6Pase, G6PDH and malic enzyme activity and of glycogen content. Prog Histochem Cytochem 1981; 14: 1\u201392.","journal-title":"Prog Histochem Cytochem"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:21:11Z","timestamp":1648614071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,29]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF3302650"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302650","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,29]]},"assertion":[{"value":"12 May 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}